PHARMACOLOGY & NEUROSCIENCE TRAINING IN DRUG ABUSE

Summary

Principal Investigator: STANLEY GLICK
Affiliation: Albany Medical College
Country: USA
Abstract: Continuation of the currently funded predoctoral and postdoctoral training program in the pharmacology and neuroscience of drug abuse is proposed. This five-year program will consist of funding for 3 predoctoral and 3 postdoctoral trainees per year. The program has already completed training 2 predoctoral students, and two are currently supported by this grant. Four postdoctoral trainees have been supported by this grant so far; one received an individual NRSA after one year of training, one completed the planned two years of training, and two are currently in training. Faculty participation is comprised of a) 15 training faculty who serve as mentors and who are either currently funded by NIDA or whose research programs can provide training relevant to drug abuse issues, and b) 5 resource faculty who contribute to the program via teaching and laboratory training. Approximately 27,500 square feet of laboratory space, a wide array of state-of-the art chemical, physiological and behavioral testing equipment, and approximately $3.5 million (direct) of federally sponsored research funds are designated annually for the research of the training faculty. The program for predoctoral trainees consists of a comprehensive neuropharmacology/neuroscience didactic curriculum which includes a course on the biology of addiction as well as related topics (e.g., effects of prenatal drug exposure, treatment of addiction) integrated into broader-based courses. Predoctoral trainees must complete research projects in three laboratories prior to choosing a mentor and developing a thesis project. Both predoctoral and postdoctoral trainees are required to attend an annual seminar program consisting of presentations by 20 invited speakers and all trainees must present a one hour research seminar annually as well. All trainees also are required to participate in a journal club course designed to teach them how to present effectively written research for publication and how to critique published literature. Training in ethical conduct of research is required of all trainees. The current and proposed program provides a multifaceted approach to understanding mechanisms of drug abuse and treatment through an integrated program of didactic work and an outstanding in-depth research experience. It is designed to train participants to become independent, ethical and skilled scientists able to make significant contributions in drug abuse research. Predoctoral training is expected to last 4-5 years; postdoctoral training duration is 2-3 years. All aspects of the program are administered by the director and an executive committee of administrative and training faculty.
Funding Period: 1999-09-30 - 2009-06-30
more information: NIH RePORT

Top Publications

  1. ncbi Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets
    Keri E Cannon
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, Albany, NY 12208, USA
    Pain 129:76-92. 2007
  2. ncbi CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist
    Lindsay B Hough
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, 47 New Scotland Avenue, Albany, NY 12208, USA
    Neuropharmacology 52:1244-55. 2007
  3. ncbi Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively
    Keri E Cannon
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, Albany, NY 12206, USA
    Pharmacol Biochem Behav 88:122-9. 2007
  4. ncbi High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain
    Rebecca Stadel
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, 47 New Scotland Ave, Albany, NY 12208, USA
    Drug Metab Dispos 36:614-21. 2008
  5. ncbi Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases
    Timothy J Harrigan
    Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA
    J Neurochem 106:2449-62. 2008
  6. ncbi Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions
    Qin Shen
    New York Neural Stem Cell Institute, Rensselaer, NY 12144, USA
    Cell Stem Cell 3:289-300. 2008
  7. ncbi Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain
    Christopher A Fasano
    Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208 USA
    Genes Dev 23:561-74. 2009

Scientific Experts

  • Christopher A Fasano
  • LINDSAY HOUGH
  • Keri E Cannon
  • Timothy J Harrigan
  • Rebecca Stadel
  • Qin Shen
  • Sally Temple
  • Shu Mien Chuang
  • Erzsebet Kokovay
  • Shu-Mien Chuang
  • Badrinath Roysam
  • Gang Lin
  • James G Phillips
  • Julia W Nalwalk
  • Susan K Goderie
  • DAVID JOURD'HEUIL
  • Jun Yang
  • Alexander A Mongin
  • Iskandar F Abdullaev
  • Yue Wang
  • Frank L Rice
  • Paul L Chazot
  • Fiona Shenton
  • Victoria Hann
  • Rob Leurs

Detail Information

Publications7

  1. ncbi Immunohistochemical localization of histamine H3 receptors in rodent skin, dorsal root ganglia, superior cervical ganglia, and spinal cord: potential antinociceptive targets
    Keri E Cannon
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, Albany, NY 12208, USA
    Pain 129:76-92. 2007
    ..Taken with recently published behavioral results, the present findings suggest that periarterial, peptidergic, H3R-containing A delta fibers may be sources of high threshold mechanical nociception...
  2. ncbi CC12, a high-affinity ligand for [3H]cimetidine binding, is an improgan antagonist
    Lindsay B Hough
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, 47 New Scotland Avenue, Albany, NY 12208, USA
    Neuropharmacology 52:1244-55. 2007
    ..Elucidation of this mechanism will enhance understanding of the biochemistry of pain relief...
  3. ncbi Activation of peripheral and spinal histamine H3 receptors inhibits formalin-induced inflammation and nociception, respectively
    Keri E Cannon
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, Albany, NY 12206, USA
    Pharmacol Biochem Behav 88:122-9. 2007
    ..Pharmacological stimulation of H3 receptors could be an important therapeutic approach for many disorders related to deep dermal or inflammatory pain...
  4. ncbi High-affinity binding of [3H]cimetidine to a heme-containing protein in rat brain
    Rebecca Stadel
    Center for Neuropharmacology and Neuroscience, Albany Medical College MC 136, 47 New Scotland Ave, Albany, NY 12208, USA
    Drug Metab Dispos 36:614-21. 2008
    ..Finally, CC12 is a new, potent inhibitor of CYP2B6 and CYP2C19 that may be a valuable tool for P450 research...
  5. ncbi Activation of microglia with zymosan promotes excitatory amino acid release via volume-regulated anion channels: the role of NADPH oxidases
    Timothy J Harrigan
    Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208, USA
    J Neurochem 106:2449-62. 2008
    ..Taken together, these data suggest that the anion channel VRAC may contribute to microglial glutamate release and that its activity is regulated by endogenous ROS originating from NOX4...
  6. ncbi Adult SVZ stem cells lie in a vascular niche: a quantitative analysis of niche cell-cell interactions
    Qin Shen
    New York Neural Stem Cell Institute, Rensselaer, NY 12144, USA
    Cell Stem Cell 3:289-300. 2008
    ....
  7. ncbi Bmi-1 cooperates with Foxg1 to maintain neural stem cell self-renewal in the forebrain
    Christopher A Fasano
    Center for Neuropharmacology and Neuroscience, Albany Medical College, Albany, New York 12208 USA
    Genes Dev 23:561-74. 2009
    ....